Amicus Therapeutics CEO John Crowley

Update: 2021-06-04

Description

In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Amicus Therapeutics CEO John Crowley

2021-06-0430:42

Economist and Author Dambisa Moyo

2021-06-0423:18

Norwegian Cruise Lines CEO Frank Del Rio

2021-06-0418:09

Malcolm Gladwell

2021-06-0442:11

Mike Sievert

2021-05-0616:04

Mary Dillon

2021-05-0617:14

Dana Perino

2021-05-0615:53

Lewis Pugh

2021-05-0618:33

Walter Isaacson

2021-04-0517:04

Sherry Turkle

2021-03-2217:42

Charles Phillips

2021-03-1917:15

Antoine Flamarion and Mathieu Chabran, Co-Founders of Tikehau Capital

2021-03-1215:49

Jens Stoltenberg

2021-03-1020:06

Christina Swarns

2021-03-0919:31

Horacio Rozanski

2021-03-0418:23

Steve Nash

2021-02-2316:35

Gregg Renfrew

2021-02-1817:04

Marcus Samuelsson

2021-02-1018:14

Thomas Ricks

2021-02-0116:55

Julian Salisbury, Global Co-Head of Asset Management at Goldman Sachs

2021-01-2811:21

00:00

Amicus Therapeutics CEO John Crowley

#box-pro-ellipsis-173242309285416{-webkit-line-clamp:2;}Amicus Therapeutics CEO John Crowley

Amicus Therapeutics CEO John Crowley

Goldman Sachs

Amicus Therapeutics CEO John Crowley